| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_49b8f128d3148eb8c4a713f0eae919fc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 |
| filingDate |
2016-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5137258cf49db46ae4e02fb774d8a6a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b92153613f4ff4290e76c3d7824ec9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e435463957befe8ee592b73104b98ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a9fc397e2e6099439b0bcd9cd9f4c4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3235c4b7e9d5890d5f91fd9bef86367
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fc6422dfaddc05f19416377d96ec9a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18e1e7fab1414641db769e913cb6087c |
| publicationDate |
2017-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3243510-A1 |
| titleOfInvention |
Sulfonamide pharmaceutical composition |
| abstract |
A sulfonamide pharmaceutical composition. The present invention relates to a sulfonamide compound injectable preparation comprising a sulfonamide compound or a derivative thereof. The injectable preparation is prepared from the sulfonamide compound and a pharmaceutically acceptable carrier through certain preparation technologies. The sulfonamide compound injectable preparation involved in the present invention is stable and controllable in quality and effective. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11752160-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022066277-A1 |
| priorityDate |
2015-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |